BACKGROUND Patients with cyanotic congenital heart disease (CCHD) have a high prevalence of thrombosis, the most frequently described locations being the cerebral and pulmonary vessels. The reported prevalence of both cerebral infarction and pulmonary thrombosis has been highly variable. The aim of this study was to examine the prevalence of both cerebral and pulmonary thrombosis in CCHD accord...

By MARCO BRUSCHI, M.D., AND JOHN S. HOWE, M.D. T HE PURPOSE of this paper is to classify the hematologic variations and abnormalities associ ated wi th Boeck’s sarcoid, to discuss whether the abnormalities are causally or coincidentally related and to present a case of thrombocytopenic purpura associated with sarcoidosis with recovery following splenectomy. It should be pointed out that althoug...

Background: Hematologic malignancies in childhood and their treatments can cause dental anomalies and jaw bone abnormalities; therefore, the aim of this study was to assess the prevalence of these disorders in children. Methods: This cross-sectional study was conducted on all children diagnosed with hematologic malignancies that referred to in Amirkola Children’s Hospital from 2011 to 2018. Al...

BACKGROUND Infants with Down syndrome are at increased risk for hematologic abnormalities, including leukemoid reaction, transient myeloproliferative disorder, and congenital leukemia. The differential diagnosis of a vesiculopustular eruption in an infant with Down syndrome and these hematologic abnormalities is broad and includes benign, self-limited disorders as well as life-threatening infec...

Studies of marrow regulation were carried out in two families with recessively expressed erythrocytosis. The erythrocytosis in the affected individuals was associated with increased erythropoietin (ESF) production. However, hormone production was uninfluenced by alterations In the 02 carrying capacity of the blood when the hematocrit was lowered acutely by phlebotomy. Hemoglobin and red cell fu...

I N A RECENT REVIEW of the clinical and epidemiologic aspects of polycythemia, Modan’ discussed familial polycythemia, which was first reported in 19072 and in several reviews subsequently.3 5 As more sophisticated diagnostic technics have become available, familial polycythemia has been recognized to be a clinical entity, distinct from polycythemia rubra vera (PRV) in its clinical, hematologic...